Business, energy, technology, markets and global industry news from Business News Today

Cologuard Plus

Medical Devices & Diagnostics

Geneoscopy’s ColoSense Medicare win puts stool RNA testing into the colorectal screening mainstream

Medicare coverage gives ColoSense a bigger test: can stool RNA screening move from FDA approval to real colorectal cancer adoption?

Read More